BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12219172)

  • 1. Recent advances in angiotensin II signaling.
    Touyz RM; Berry C
    Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
    Touyz RM; Schiffrin EL
    Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
    Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
    J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
    Cui T; Nakagami H; Iwai M; Takeda Y; Shiuchi T; Daviet L; Nahmias C; Horiuchi M
    Cardiovasc Res; 2001 Mar; 49(4):863-71. PubMed ID: 11230986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
    Eguchi S; Iwasaki H; Inagami T; Numaguchi K; Yamakawa T; Motley ED; Owada KM; Marumo F; Hirata Y
    Hypertension; 1999 Jan; 33(1 Pt 2):201-6. PubMed ID: 9931105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.
    Touyz RM; Schiffrin EL
    Pharmacol Rev; 2000 Dec; 52(4):639-72. PubMed ID: 11121512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in intracellular signalling in hypertension.
    Touyz RM
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracellular signaling pathways of angiotensin II receptor type 1 involved in the development of cardiovascular diseases].
    Miyazaki H; Shibata T; Fujii N
    Nihon Rinsho; 1998 Jul; 56(7):1906-11. PubMed ID: 9702074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
    Mehta PK; Griendling KK
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C82-97. PubMed ID: 16870827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.
    Meloche S; Pelletier S; Servant MJ
    Mol Cell Biochem; 2000 Sep; 212(1-2):99-109. PubMed ID: 11108141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases.
    Berk BC
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S62-8. PubMed ID: 9892142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-triggered kinase signaling cascade in the central nervous system.
    Bali A; Jaggi AS
    Rev Neurosci; 2016 Apr; 27(3):301-15. PubMed ID: 26574890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
    Balakumar P; Jagadeesh G
    Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.
    Saito Y; Berk BC
    J Mol Cell Cardiol; 2001 Jan; 33(1):3-7. PubMed ID: 11133218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
    Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
    Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II signaling pathways mediated by tyrosine kinases.
    Yin G; Yan C; Berk BC
    Int J Biochem Cell Biol; 2003 Jun; 35(6):780-3. PubMed ID: 12676164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
    Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.